Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

August 20, 2014

Primary Completion Date

July 24, 2018

Study Completion Date

July 22, 2024

Conditions
Prostate Cancer
Interventions
DRUG

ELIGARD

"Hormone therapy is recommended Eligard 45 mg acting for 6 months. It will be ideally administered the day of start of radiation therapy or within 3 months before the first day of radiotherapy.~Nevertheless, free prescription is left to investigators. When using other hormonal strategies (anti-androgen agonists, LHRH antagonists or LHRH), an administration for six months will be critical."

Trial Locations (2)

44800

ICO René Gauducheau, Saint-Herblain

Unknown

ICO Paul Papin, Angers

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Astellas Pharma Inc

INDUSTRY

lead

Institut Cancerologie de l'Ouest

OTHER